The January and July 2010 SRTR (Scientific Registry of Transplant Recipients) data continue to report our 1-month, 1-year and 3-year patient and graft survival rates to be well above national average.
The July 2008 SRTR data reported the NewYork-Presbyterian/Columbia University Center for Lung Disease and Transplantation to have the highest three-year Patient and Graft Survival rates compared nationally to the other Lung transplant Centers in the US.
During 2006, the NewYork-Presbyterian/Columbia University Center for Lung Disease and Transplantation had the highest one-year survival rate among the 10 largest lung transplant programs in the U.S., and its survival rates during 2006 placed it among the top three programs in the nation.
Lung transplantation can prolong and dramatically improve the quality of life for patients with severe end-stage, non-malignant pulmonary disease and no alternative treatment options.
The major center for lung transplantation in the New York tri-state area, the NewYork-Presbyterian Hospital/Columbia University Medical Center Center for Lung Disease and Transplantation is one of the oldest in the United States—it was established in 1985, just three years after the first lung transplant was ever performed.
Over the years, the center has earned a reputation for the depth of its clinical expertise and rigorous commitment to excellence.
Studies at the center continue to improve treatment options, prevent or delay the progression of serious lung diseases, and improve the quality of life and survival for patients.
These achievements have been most notable in the areas of emphysema, idiopathic pulmonary fibrosis, pulmonary arterial hypertension, and cystic fibrosis.
The center is Medicare approved, and treats both adults and adolescents.
Under the dynamic and collaborative leadership of its surgical and medical directors, both recognized as outstanding specialists in their respective fields, this highly reputable clinical and research center has been further enhanced and expanded.
As evidence, its patient survival rates have soared far above the national average.
Between July 1, 2001 and July 31, 2008, the center performed 274 lung transplants, with a one-year survival rate of 92%, compared to 82% nationally, and a three-year survival rate of 78%, compared to 65% nationally.
Survival of 274 consecutive patients transplanted at Columbia University compared to 8,179 patients transplanted nationwide between July 1, 2001 and July, 31, 2008 (p < 0.001). National average data source: United Organ Sharing Network (UNOS)
Coordinated and Comprehensive Pulmonary Care
At age 31, cystic fibrosis patient Timothy Sweeney needed a double lung transplant. Less than one year later, he ran the New York
City Marathon with his transplant surgeon, Joshua Sonett, MD. Hear his story here.
Note: there are two videos, one immediately following the other.
All lung transplant patients at the NewYork-Presbyterian/Columbia University Center for Lung Disease and Transplantation receive individualized care reflecting their specific medical, surgical and psychosocial needs — from the moment they begin their first evaluation through their extensive post-transplant follow-up care.
Experts in every medical and surgical specialty relating to lung failure and transplantation participate in the Lung Transplant Center.
It draws upon the skills and expertise of not only surgeons, pulmonologists, immunologists and endocrinologists, but also nurse practitioners, registered nurses, physician's assistants, intensive care clinicians, rehabilitation medicine specialists, physical and respiratory therapists, social workers, psychiatrists, nutritionists, and financial counselors.
The collaboration among these outstanding clinicians and research scientists leads to optimal patient care.
In addition, the patient's referring physicians also continue to participate in the primary pulmonary care of their patients and are kept abreast of all stages of the transplant process via telephone calls or letters from the transplant medical and surgical team.
In addition to lung transplant evaluation, the center's pulmonary specialists provide second opinion consultations for patients with complex lung diseases.
At the NewYork-Presbyterian/Columbia University Center for Lung Disease and Transplantation's Beverly & Arthur Shorin Comprehensive Outpatient Transplant Center, patients may take advantage of comprehensive follow-up care, including evaluation and follow-up, blood and diagnostic testing, and infusion treatments for special medications.
The registration and care process at the Shorin Center is managed with the latest technology to enhance convenience and precision.
The center also works in conjunction with other parts of the NewYork-Presbyterian Hospital system.
Click here to learn more about our medical facilities.
